Table 3. Univariate and multivariate analyses in two cohorts.
Variables | Discovery cohort | Validation cohort | |||||||||
Univariate analysis | Multivariate analysis | Univariate analysis | Multivariate analysis | ||||||||
HR (95% CI) | P | HR (95% CI) | P | HR (95% CI) | P | HR (95% CI) | P | ||||
IS-mod, modified Immunoscore; HR, hazard ratio; 95% CI, 95% confidence interval. | |||||||||||
Age | 1.03 (1.01−1.06) | 0.004 | 1.03 (1.01−1.05) | 0.021 | 1.01 (0.98−1.04) | 0.631 | |||||
Sex | |||||||||||
Male | 1 | 1 | |||||||||
Female | 1.02 (0.62−1.68) | 0.947 | 1.37 (0.59−3.17) | 0.468 | |||||||
Stage | |||||||||||
I | 1 | 1 | |||||||||
II | 3.96 (0.52−30.1) | 0.184 | 3.87 (0.51−29.5) | 0.191 | 1 | 1 | |||||
III | 14.8
(2.04−107) |
0.008 | 11.5 (1.59−83.8) | 0.016 | 4.85 (1.64−14.4) | 0.004 | 3.30 (1.01−9.17) | 0.049 | |||
Location | |||||||||||
Cecum ascending | 1 | 1 | |||||||||
Descending | 0.43 (0.15−1.22) | 0.113 | 0
(0−Inf) |
0.997 | |||||||
Sigmoid | 0.81 (0.48−1.37) | 0.429 | 0.69 (0.26−1.85) | 0.466 | |||||||
Transverse | 0.54 (0.13−2.25) | 0.379 | 0.68 (0.23−1.97) | 0.477 | |||||||
IS-mod | |||||||||||
Low | 1 | 1 | 1 | 1 | |||||||
High | 0.28 (0.16−0.49) | <0.001 | 0.36 (0.20−0.63) | <0.001 | 0.11 (0.02−0.46) | 0.003 | 0.15 (0.03−0.67) | 0.013 |